Glivec (imatinib) CML and GIST Treatment Glivec, CML, and GIST Treatment Information for International Healthcare Professionals Glivec, CML  and GIST Treatment Information for US Residents International Glivec Information from Novartis Oncology Click here to go to Novartis.com Novartis Oncology International Site
International Glivec Information from Novartis Oncology
Ask a question
Haematology and Oncology News from Glivec.com

Our weekly newsletter keeps you informed of the latest haematology and oncology news.

Help us improve Glivec.com.
Please take our short survey.

Print Glivec Information from Novartis Oncology emial
 

The resources below will help you learn more about CML, including its diagnosis and its treatment with Glivec (imatinib).

Targeted Therapy in Gastrointestinal Stromal Tumours (GIST) based on data presented at ASCO in 2007.

Advanced GIST Case Study Monograph (PDF)*

To learn more about the human impact of Glivec, read the GIST Patient Brochure*

GIST Clinical Monograph (PDF), a clinical monograph of the disease

Side-effect Management (PDF)

GIST Molecular Target animation, a short animation on GIST.**



References :

* Some resources are in PDF format. You need Adobe ® Reader ®, available free from Adobe, to download, view and print PDF files.


** Animations can be viewed with Apple Quicktime. At 56kbps, download time is estimated at about 25 minutes.


Disclaimer: This is an international website for Glivec (imatinib) and is intended for healthcare professionals outside the US. If you are a US resident, please click on the For US Residents link at the top of this page. The information on this site is not country-specific and may contain information that is outside the approved indications in the country in which you are located.



Use of this website is subject to our Terms of Use.
© 2008 Novartis Pharma AG